Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Degenhardt, Fiona J Charlson, Alize J Ferrari, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 12, pp. 987-1012
Open Access | Times Cited: 1242

Showing 1-25 of 1242 citing articles:

Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

The Lancet Psychiatry (2022) Vol. 9, Iss. 2, pp. 137-150
Open Access | Times Cited: 3474
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Alize J Ferrari, Damian Santomauro, Amirali Aali, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2133-2161
Open Access | Times Cited: 1170
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra, Arka De, Abhijit Chowdhury
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 16-16
Open Access | Times Cited: 422
The path to healthy ageing in China: a Peking University–Lancet Commission
Xinxin Chen, John Giles, Yao Yao, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1967-2006
Open Access | Times Cited: 418
COVID-19 and addiction
Mahua Jana Dubey, Ritwik Ghosh, Subham Chatterjee, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 817-823
Open Access | Times Cited: 335
Cannabis use and cannabis use disorder
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 308
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Wayne Hall, Daniel Stjepanović, Jonathan P. Caulkins, et al.
The Lancet (2019) Vol. 394, Iss. 10208, pp. 1580-1590
Closed Access | Times Cited: 291
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019
Rui Wang, Zhaoqi Li, Shaojun Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e065186-e065186
Open Access | Times Cited: 279
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
Adrian Dunlop, Buddhima Lokuge, Debbie Masters, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 243
One Is Not Enough: Understanding and Modeling Polysubstance Use
Elizabeth A. Crummy, Timothy J. O’Neal, Britahny M. Baskin, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 235
Retention of patients in opioid substitution treatment: A systematic review
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232086-e0232086
Open Access | Times Cited: 226
Addiction as a brain disease revised: why it still matters, and the need for consilience
Markus Heilig, James MacKillop, Diana Martínez, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 10, pp. 1715-1723
Open Access | Times Cited: 206
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030
Liyuan Pu, Li Wang, Ruijie Zhang, et al.
Stroke (2023) Vol. 54, Iss. 5, pp. 1330-1339
Open Access | Times Cited: 202
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
Giulio Castelpietra, Ann Kristin Knudsen, Emilie Agardh, et al.
The Lancet Regional Health - Europe (2022) Vol. 16, pp. 100341-100341
Open Access | Times Cited: 201
Screening for Unhealthy Drug Use
Alex H. Krist, Karina W. Davidson, Carol M. Mangione, et al.
JAMA (2020) Vol. 323, Iss. 22, pp. 2301-2301
Open Access | Times Cited: 199
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman, Chandni Hindocha, Gianluca Baio, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 10, pp. 865-874
Open Access | Times Cited: 172
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study
Lindsay A Pearce, Jeong Eun Min, Micah Piske, et al.
BMJ (2020), pp. m772-m772
Open Access | Times Cited: 155
Buprenorphine Treatment for Opioid Use Disorder: An Overview
Matisyahu Shulman, Jonathan Wai, Edward V. Nunes
CNS Drugs (2019) Vol. 33, Iss. 6, pp. 567-580
Open Access | Times Cited: 149
Psychological, addictive, and health behavior implications of the COVID-19 pandemic
Michael J. Zvolensky, Lorra Garey, Andrew H. Rogers, et al.
Behaviour Research and Therapy (2020) Vol. 134, pp. 103715-103715
Open Access | Times Cited: 147
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Nora D. Volkow, Carlos Blanco
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 203-229
Open Access | Times Cited: 137
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 136
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review
Louisa Degenhardt, Paige Webb, Samantha Colledge‐Frisby, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 5, pp. e659-e672
Open Access | Times Cited: 134
The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review
Rose A. Schmidt, Rosalie Genois, Jonathan Jin, et al.
Drug and Alcohol Dependence (2021) Vol. 228, pp. 109065-109065
Open Access | Times Cited: 132
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 112
The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019
Huilong Chen, Yuan Zhan, Kaimin Zhang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top